Nantahala Capital Management, LLC - Dec 31, 2024 Form SCHEDULE 13G Schedule Report for INHIBIKASE THERAPEUTICS, INC. (IKT)

Filing Manager
Nantahala Capital Management, LLC
Reporting Manager
Nantahala Capital Management, LLC
Security
INHIBIKASE THERAPEUTICS, INC. Common Stock, $0.001 par value
Symbol
IKT
Shares outstanding
70.3M shares
Disclosed Ownership
5.3M shares
Ownership
7.54%
Form type
SCHEDULE 13G
Date filed
2/14/2025, 04:32 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nantahala Capital Management, LLC 7.54% 5.3M 0 5.3M /s/ Taki Vasilakis Taki Vasilakis / Chief Compliance Officer
Wilmot B. Harkey 7.54% 5.3M 0 5.3M /s/ Wilmot B. Harkey Wilmot B. Harkey
Daniel Mack 7.54% 5.3M 0 5.3M /s/ Daniel Mack Daniel Mack